Introduction
============

Anabolic androgenic steroids (AAS) are misused by athletes because of their anabolic properties. Main functions of AAS are stimulation of protein synthesis and an antiglucorticoid effect which increases muscle mass and strength. They influence the central nervous system and increase motivation and performance ([@b7-bmi-2009-001]; [@b12-bmi-2009-001]; [@b13-bmi-2009-001]; [@b11-bmi-2009-001]; [@b14-bmi-2009-001]). The International Olympic Committee banned the use of synthetic AAS in 1974 by athletes but today doping is still a big topic in almost all kinds of sport. The world anti doping agency (WADA) encourages drug testing laboratories to develop methods to detect AAS like testosterone, 17β-nortestosterone and stanozolol that are the most frequently found steroids in doping samples ([@b14-bmi-2009-001]; [@b5-bmi-2009-001]; [@b21-bmi-2009-001]). Common used methods in doping analysis are mass spectrometry (MS) based techniques, that directly detect the AAS or their metabolites in different tissues like urine, blood or hair samples. Especially the hair is a very interesting tissue for drug residue analysis because hormones are detectable over a long time and the samples are easily to collect by a non invasive manner ([@b10-bmi-2009-001]; [@b4-bmi-2009-001]; [@b27-bmi-2009-001]; [@b2-bmi-2009-001]; [@b1-bmi-2009-001]; [@b9-bmi-2009-001]). The intake of AAS influences the organism in many different ways. It can be supposed that these hormonally provoked changes in the metabolism can be seen on the level of mRNA gene expression (Reiter et al. 2007). Taking the hair root to analyse these expressions it is known that androgens act via the dermal papilla cells and influence different kind of growth factors and enzymes ([@b25-bmi-2009-001]).

The aim of this feasibility study was to investigate regulated target genes in hair follicle cells to identify possible mRNA gene expression regulations aroused by stanozolol. Target genes were selected in functional groups to facilitate the identification of possible biomarker for the different hormones.

Materials and Methods
=====================

Reagent
-------

The anabolic steroid stanozolol (S, 17β-Hydroxy-17α-methyl-androstano\[3,2-c\]pyrazole), was received from Sigma-Aldrich (Taufkirchen, Germany) with cell culture grade purity. For treatment the reagents was dissolved in 100% ethanol to a concentration 1mg/ml and diluted with cell culture medium to 1 nM, 10 nM and 100 nM.

Experiment
----------

Two HFDPC (hair follicle dermal papilla cell) cultures, one from a female (cell culture 1) and one from a male (cell culture 2) donor were treated in different concentrations with the anabolic steroid stanozolol and taken at different treatment time points.

Cell culture 1
--------------

Human HFDPC were ordered from Cell Applications (San Diego, U.S.A). Cells had been cultivated from skin samples of the temple taken during plastic surgery at a 49 year-old, female patient. After establishing a primary cell culture the cells were frozen in serum-free freezing medium and sent cryopreserved (500,000 cells in 1ml). A ready-to-use HFDPC Medium and Supplement Kit (Cell Applications, San Diego, U.S.A) was taken to cultivate the cells, containing Basal Medium, FCS (fetal calf serum), growth factors and antibiotics. For sub cultivation served a kit containing HBSS (HEPES buffered saline solution), trypsin/EDTA solution and neutralizing solution (Cell Applications, San Diego, U.S.A).

The thawed cells were cultivated in collagen coated T-75 flasks (Cell Applications, San Diego, U.S.A) containing 15 ml HFDPC medium at 37 °C in a humidified atmosphere of 5% CO~2~ and sub-cultivated at 85% confluence. Cells were frozen and stored at −80 °C after each splitting that was up to the sixth passage. For the experiment cells from third passage were thawed, given into 12-well plates (ca. 3.4 × 10^4^/well) and cultivated till 85% confluence. Cells were cultured in triplicates with 0 nM (control-treatment), 1 nM, 10 nM and 100 nM stanozolol groups on each plate, sampling took place at 0 h (control-time), 6 h, 24 h and 48 h.

To remove natural containing steroids for all experiments the FCS was stripped by using charcoal, as described by [@b6-bmi-2009-001].

Cell culture 2
--------------

Human HFDPC cells were ordered from Promo Cell (Heidelberg, Germany). Cells had been cultivated from skin samples of the temple taken during plastic surgery at a 40 year-old, male patient. After establishing a primary cell culture the cells were frozen in serum-free freezing medium and sent cryopreserved (500,000 cells in 1ml). A ready-to-use HFDPC Medium and Supplement Kit (Promo Cell, Heidelberg, Germany), containing Basal Medium, FCS (fetal calf serum), basic FGF and Insulin was additionally ordered to cultivate the cells. For sub cultivation served a kit containing HBSS (HEPES buffered saline solution), trypsin/EDTA solution and neutralizing solution (Promo Cell, Heidelberg, Germany).

Cells were cultivated in T-75 flask with 15 ml Medium at 37 °C in a humidified atmosphere of 5% CO~2~ and sub-cultivated at 85% confluence. Collagen coating was not executed because it was not recommended by the supplier. Cells were frozen and stored at −80 °C after each splitting that was up to the sixth passage. For the experiment the cells from third passage were given into 12-well plates (ca. 3.4 × 10^4^/well) and cultivated till 85% confluence. Cells were cultured in triplicates with 0 h (control-treatment), 10 nM and 100 nM stanozolol groups on each plate, sampling took place 0h (control-time), 6 h, 24 h and 72 h.

For treatment, steroids were removed from FCS, as described by [@b6-bmi-2009-001].

RNA extraction and RNA quality
------------------------------

Total RNA was isolated from HFDPC cells using TriFast (peqLab Biotechnologie GmbH, Erlangen, Germany). The standardized protocol from the supplier was used for the extraction. The principal of this protocol was phenol/chloroform extraction for total RNA. Extracted RNA was dissolved in 10 μl RNAse free water. To quantify the amount of total RNA extracted, optical density (OD) was measured with the photometer (Eppendorf Biophotometer, Hamburg, Germany) for each sample.

RNA integrity and quality control was performed with the Bioanalyzer 2100 (Agilent Technology, Palo Alto, U.S.A). For sample analysis eukaryotic total RNA Nano Assay (Agilent Technology) was taken and the RNA Integrity Number (RIN) served as RNA quality parameter ([@b8-bmi-2009-001], [@b23-bmi-2009-001]). In order to the expected high quality of the total RNA from cell cultures, a set of selected samples from the 6 h treatment were measured as quality references.

Selection of target genes
-------------------------

Target genes (TG) were selected according to their possible role in the anabolic pathways in the hair follicle. Following TG were chosen as markers by screening the respective literature. Because of the limited total RNA amount, TG were taken for analysis that seemed to be highly influenced by steroids and could show possible gene expression regulations.

Factors of apoptosis regulation were Fas receptor ligand (FasL), Fas receptor (FasR), Caspase 8 and the anti-apototic factor Bcl-2. Androgen receptor (AR) and the estrogen receptors (ERα, ERβ) were summarized in the steroid receptor group. The growth factor group included the insulin like growth factor receptor (IGF1R) and growth hormone receptor (GHR). Fibroblast growth factor 2 (FGF2) and keratinocyte growth factor (FGF7) were summarized in the hair cycle factor group. 5α-Steroidreductases (SRD5A1, SRD5A2) represented the enzyme group.

Ubiquitin (UBQ), glycerinaldehyde-3-phsophate-dehydrogenase (GAPDH) and β-actin (ACTB) were taken as reference genes for relative quantification method.

Primer design and testing
-------------------------

All primers were designed using published nucleic acid sequences of "Ensembl Genom Browser" (<http://www.ensembl.org>) and NCBI ([www.ncbi.nlm.nih.gov](www.ncbi.nlm.nih.gov)). Primer design and optimization was done with primer design program primer 3 (<http://frodo.wi.mit.edu/>) with regard to primer dimer formation, self-priming formation and primer annealing temperature at 60 °C. Designed primers were ordered, synthesized and shipped by MWG Biotech (Ebersberg, Germany). Primer testing was performed with a pooled RNA sample of several hair samples, as positive control and RNAse free water as negative control (Qiagen, Hilden, Germany) for each primer set. Generated PCR products were checked for length and primer dimer formation by an agarose gel electrophoresis. All primer sequences, their amplicon size and annealing temperatures are illustrated in [Table 1](#t1-bmi-2009-001){ref-type="table"}.

Real-time qRT-PCR
-----------------

Quantitative real-time RT-PCR was performed at the Rotor Gene 6000 (Corbett Life Science, Sydney, Australia) using SuperScript III Platinum SYBR Green One-Step qPCR Kit (Invitrogen, Carlsbad, U.S.A) by using standard protocol of the supplier. Samples were diluted to 10 ng/μl. For mRNA protection, additionally 50 ng tRNA in 5 μl (Invitrogen, Carlsbad, U.S.A) were added to each sample. 3.8 μl of total RNA solution were taken for one PCR reaction in a total volume of 10 μl. Threshold cycle (Ct) and melting curves were acquired by using the *"quantitation" and "melting curve"* program of the Rotor-Gene 6000 analysis software.

Only genes with clear and single melting peaks were taken for further data analysis. Samples with irregular melting peaks were excluded from the calculation. All samples were baseline corrected and threshold was set manually, using identical threshold levels for one gene in all analyzed samples.

Data Analysis and Statistics
----------------------------

Data were processed applying relative quantification method comparable to the ΔΔCt-method (2^−ΔΔCt^) ([@b15-bmi-2009-001]). Expression changes are shown as relative up- or down-regulation normalized by three internal reference genes. For normalization of target gene expression the arithmetic mean (AM) of the following reference genes (RG) were taken: (RG1) GAPDH, (RG2) ACTB and (RG3) UBQ. The mean values served as reference gene index (RGI). RG were excluded when showing significant regulation by treatment or time. This was calculated using the t-test algorithm in Excel (Microsoft, U.S.A). This value was then taken to do normalization and calculate the ΔCt by subtracting the Ct of the RG-Index (RGI) from the Ct of the target gene (TG).

RGI (cell culture 1) = AM (Ct~ACTB~; Ct~GAPDH~; Ct~UBQ~)

RGI (cell culture 2) = AM (Ct~GAPDH~; Ct~UBQ~)

ΔCt = Ct ~(RGI)~ − Ct ~(TG)~

In a second step the normalized gene expression values were set in relation to the control group (ΔΔCt).

ΔCt ~(control/treatment)~ = mean ΔCt value of control treatment

ΔΔCt = ΔCt ~(treatment)~ − ΔCt ~(control/treatment)~

To show up- and down-regulations of the TG the ratio was calculated provided that DNA was doubled per cycle (2^ΔΔCt^).

Ratio = 2^ΔΔ^~Ct~

Regulations over treatment time were calculated using a 2-Way-Anova with SigmaStat Software. In Excel (Microsoft, U.S.A) ΔΔCt was calculated and statistical analyses were done by using the t-test. All data are illustrated by means ± standard deviation (SD).

Results
=======

RNA concentration and RNA integrity
-----------------------------------

Samples of the cell culture 2 showed a slightly higher mean RNA yield (144.78 ng/μl) compared to the samples of the cell culture 1 (76.9 ng/μl). For the 6 h treatment samples average RIN values were quite similar in cell culture 1 (8.8 ± 0.5) and in cell culture 2 (8.6 ± 2.9).

Primer testing and PCR
----------------------

From 19 designed and tested primer pairs three genes did not showed satisfactory PCR results, concerning verifiability, melting curve analysis and in agarose gel electrophoresis. Therefore, FasL, ERα and ERβ were excluded from analysis. All other genes were accepted for further analysis.

Gene regulation under Stanozolol treatment
------------------------------------------

Because the reference gene ACTB showed a significant regulation under stanozolol treatment in cell culture 2, only GAPDH and UBQ were taken for RGI calculation.

Gen expression analysis within one treatment time point (ΔΔCt)
--------------------------------------------------------------

In both cell cultures AR showed a significant down regulation after 24 h and FasR an up- regulation after 6 h of stanozolol treatment. In cell culture 1 the regulation of AR was seen in the 1nM concentration (p = 0.047), in cell culture 2 in the 100 nM concentration (p = 0.014). FasR was up-regulated at 6 h for 10 nM concentration in cell culture 1 (p = 0.023) and cell culture 2 (p = 0.049). Additionally FGF7 was down-regulated at 0 h (100 n M, p = 0.009, 10 nM, p = 0.0d46) and at 6 h (100 nM, p = 0.03) in cell culture 1, in cell culture 2 SRD5A2 (6 h, 100 nM, p = 0.028) and FGF2 (0 h, 100 nM, p = 0.010) showed a significant down-regulation ([Figs. 1](#f1-bmi-2009-001){ref-type="fig"}, [2](#f2-bmi-2009-001){ref-type="fig"}).

Gen expression over treatment time (2-Way-Anova)
------------------------------------------------

In the 2-Way-Anova one significant combination of Caspase 8 to treatment concentration (p-value = 0.010) and treatment time (p-value = 0.028) could be calculated in cell culture 1. Caspase 8 in the 1nM concentration was significantly different from all other concentrations and significant differences between 0 h to 6 h (p-value = 0.035) and 0h to 48 h (p-value = 0.029) could be measured for this gene.

Discussion
==========

In the present study it was tested weather the AAS stanozolol induces specific gene expression regulations in HFDPC. Taking the indicated target genes, first potential genes for an expression pattern could be identified. As feasibility study the experiments were done in cell culture to identify a set of target genes possibly interesting for further analysis in human hair follicle samples.

As expected, all cell culture samples showed a very high RNA quality, a precondition for good qRT-PCR results.

Significant regulations over the time period of treatment were supposed to show trends in gene regulations. The separation in different functional groups could help to identify gene dependent pathways in the hair papilla. Significant influences of stanozolol on gene expression could be shown up to an incubation time of 24 h. After this time the xenobiotic steroid seems to have less influence on gene expressions. This kind of time dependent gene expression regulations were also shown in other studies ([@b3-bmi-2009-001]; [@b24-bmi-2009-001]). Most regulations could be seen at 10 nM and 100 nM treatment levels. In both cell cultures AR and FasR showed the same gene expression characteristics under stanozolol treatment at the same time point of treatment. FasR additionally showed comparable regulations at the same hormone concentration. This makes AR and FasR to the first interesting candidate genes for a gene expression pattern of stanozolol. Also a possilbet gender specific difference could be seen because in the male cells the effects of the treatment seemed to induce regulations earlier (6 h) than in the female samples (24 h) ([@b16-bmi-2009-001]).

Next to the gender specific effects on gene regulation also the growth phase of the hair follicle could influence the results. A first hind for this assumption could be the different regulations of FGF2 and FGF7 in the untreated samples in both cultures. FGF7 is known to induce the growth phase (anagen phase) in the hair follicle, whereas FGF2 could be taken as its antagonist by inhibiting the morphogenesis ([@b25-bmi-2009-001]). In cell culture 1 FGF7 was significantly down-regulated what would show that these cells were taken from a hair follicle in the catagen phase. In cell culture 2 FGF2 was significantly down-regulated, indicating the anagen phase. Anyhow the significant regulation of FGF2 was a surprise because several studies identified this factor in the hair follicle but not in the hair papilla ([@b17-bmi-2009-001]; [@b18-bmi-2009-001]; [@b22-bmi-2009-001]).

The significant regulation of FasR and Caspase 8 in cell culture 1 showed first influences on metabolic pathways. The regulation of both factors could indicate a possible influence of stanozolol on the extrinsic way of apoptosis ([@b20-bmi-2009-001]).

The significant regulation of IGF1-R is supposed to be an effect of the HFDPC medium because this was already analysed in different studies before ([@b19-bmi-2009-001]; [@b28-bmi-2009-001]; [@b26-bmi-2009-001]).

Conclusion
==========

In this feasibility study first steps toward a new screening method via gene expression analysis in hair follicle were explored. A set of 10 genes was tested in cell culture to identify possible candidate genes and physiological influences of stanozolol in the hair papilla. Factors like gender and growth phase of the hair follicle seem to influence gene expression patterns in the cells. Additionally FGF2 known to be expressed in the hair follicle was identified in the hair papilla. AR and FasR can be taken as first candidate genes for a stanozolol treatment pattern because they showed same regulations at the same time point in male and female cell cultures.

Further studies are needed to identify more candidate genes and exclude individual differences in gene expression. Anyhow, in the future the identified substance specific candidate genes could be used for further analysis in hair follicle samples taken from athletes to identify possible treatment with anabolic agents. This could be supportive of the existing test methods in doping analysis and could be an additional proof for illegal drug abuse.
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![Significant gene expression regulations in cell culture 1. The ratio was calculated by 2^ΔΔCt^ whereby the control was set 1 (upper control line). Data are depicted in bars + standard deviations. Red crosses (\*) mark the significantly regulated target genes.](bmi-2009-001f1){#f1-bmi-2009-001}

![Significant gene expression regulations in cell culture 2. The ratio was calculated by 2^ΔΔCt^ whereby the control was set 1 (upper control line). Data are depicted in bars + standard deviation. Red crosses (\*) mark the significantly regulated target genes.](bmi-2009-001f2){#f2-bmi-2009-001}

###### 

List of used primer pairs, showing the length of the amplicon (nt), the melt temperature (Tm in °C) and the accession number of the sequence.

  --------------------------------------------------------------------------------------------------------
  Group               Identity          Sequence 5'-3'         Amplicon (nt)   Tm (°C)   Acces. Nr.
  ------------------- ----------- ----- ---------------------- --------------- --------- -----------------
  Enzymes             SRD5A1      FOR   CTT GAG CCA TTG\       166             58        ENST00000233239
                                        TGC AGT GT                                       

                                  REV   GCC TCC CCT TGG TAT\                             
                                        TTT GT                                           

                      SRD5A2      FOR   TGA ATA CCC TGA TGG\   181             60        ENST00000233139
                                        GTG GT                                           

                                  REV   GGA AAT TGG CTC\                                 
                                        CAG AAA CAT A                                    

  Growth factors      GHR         FOR   ATC CAC CCA TTG\       246             60        NM00163
                                        CCC TCA AC                                       

                                  REV   ATC TCA CAC GCA CTT\                             
                                        CAT ATT CC                                       

                      IGF1R       FOR   CAT TTC ACC TCC ACC\   151             60        NM000875
                                        ACC AC                                           

                                  REV   AGG CAT CCT GCC\                                 
                                        CAT CAT AC                                       

  Hair cycle          FGF2        FOR   AGA AGA GCG ACC\       237             60        M27968
                                        CTC ACA TC                                       

                                  REV   ACT GCC CAG TTC\                                 
                                        GTT TCA GT                                       

                      KGF/FGF7    FOR   CCT GAG CGA CAC\       167             60        M60828
                                        ACA AGA AG                                       

                                  REV   GCC ACT GTC GCT\                                 
                                        TCC TTA TT                                       

  Apoptosis factors   FasR        FOR   TTC TGC CAT AAG CCC\   174             60        NM000043
                                        TGT CC                                           

                                  REV   CCA CTT CTA AGC CAT\                             
                                        GTC CTT C                                        

                      bcl2        FOR   GAG GAT TGT GGC\       170             60        NM000633
                                        CTT CTT TGA G                                    

                                  REV   ACA GTT CCA CAA\                                 
                                        AGG CAT CCC                                      

                      Caspase 8   FOR   TGG CAC TGA TGG\       230             60        NM001228
                                        ACA GGA G                                        

                                  REV   GCA GAA AGT CAG\                                 
                                        CCT CAT CC                                       

  Steroid receptors   AR          FOR   TTG TCC ATC TTG TCG\   237             60        L29496
                                        TCT TCG G                                        

                                  REV   TGT CCA GCA CAC\                                 
                                        ACT ACA CC                                       

  Reference genes     UBQ         FOR   TGA AGA CTC TGA CTG\   128             60        NM021009
                                        GTA AGA CC                                       

                                  REV   CAT CCA GCA AAG ATC\                             
                                        AGC CTC                                          

                      GAPDH       FOR   GAA GGT GAA GGT\       233             60        NM002046
                                        CGG AGT CAA                                      

                                  REV   GCT CCT GGA AGA\                                 
                                        TGG TGA TG                                       

                      ACTB        FOR   AGTCCTGTGGCATCC\       78              60        NM01101
                                        ACGAAAC                                          

                                  REV   GCAGTGATCTCCTTCT\                                
                                        GCATCC                                           
  --------------------------------------------------------------------------------------------------------
